In Vitro Assessment of the Further Potential for Development of Fluoroquinolone Resistance in Neisseria meningitidis
Open Access
- 1 May 2005
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (5) , 1753-1760
- https://doi.org/10.1128/aac.49.5.1753-1760.2005
Abstract
We examined the potential for the development of fluoroquinolone resistance in Neisseria meningitidis by cultivating two clinical isolates of meningococci in the presence of concentrations of ciprofloxacin at and about the predetermined MIC. The quinolone resistance determining regions (QRDRs) of gyrA and parC of 50 stable quinolone-resistant mutants derived in vitro were sequenced and compared with QRDR alterations reported in clinical isolates of quinolone-resistant meningococci and gonococci. MICs to ciprofloxacin and trovafloxacin were determined and sequence changes were correlated with quinolone MICs. Ciprofloxacin and trovafloxacin MICs of the in vitro-derived quinolone-resistant mutants ranged up to 16 mg/liter. Single GyrA alterations were the first change detected and were accompanied by raised MICs, followed by double GyrA changes and still higher MICs. MICs increased further as single ParC substitutions appeared and these were always in the presence of a single or double GyrA change. GyrA changes occurred at positions 91 and 95 with substitutions of Asp-95→Asn and Thr-91→Ala and Ile. Changes in the parC QRDR occurred at positions 85, 86, and 91 with four substitutions, Gly-85→Asp, Asp-86→Asn, Glu-91→Gly, and Glu-91→Lys, detected. The nature of the individual QRDR substitution appeared to influence the level of quinolone resistance expressed, and this varied with the quinolone agent examined. Close similarities occurred between the sequence and nature of QRDR changes in clinical and in vitro-generated quinolone-resistant mutants and with those previously reported for clinical and in vitro-generated quinolone-resistant gonococci. This suggests that quinolone resistance in meningococci may arise in the same manner and reach similar levels in vivo to those seen in quinolone-resistant Neisseria gonorrhoeae.Keywords
This publication has 26 references indexed in Scilit:
- Quinolone Resistance Mechanisms in PneumococciClinical Infectious Diseases, 2004
- Quinolone Resistance Mechanisms in PneumococciClinical Infectious Diseases, 2004
- The NorM Efflux Pump of Neisseria gonorrhoeae and Neisseria meningitidis Recognizes Antimicrobial Cationic CompoundsJournal of Bacteriology, 2003
- Mutations in ponA , the Gene Encoding Penicillin-Binding Protein 1, and a Novel Locus, penC , Are Required for High-Level Chromosomally Mediated Penicillin Resistance in Neisseria gonorrhoeaeAntimicrobial Agents and Chemotherapy, 2002
- Genetic Analyses of Mutations Contributing to Fluoroquinolone Resistance in Clinical Isolates of Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 2001
- Correlation of In Vitro Susceptibilities to Newer Quinolones of Naturally Occurring Quinolone-Resistant Neisseria gonorrhoeae Strains with Changes in GyrA and ParCAntimicrobial Agents and Chemotherapy, 2001
- Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone‐resistant isolatesMolecular Microbiology, 1994
- Characteristics of Neisseria gonorrhoeae isolated in Australia showing decreased sensitivity to quinolone antibioticsPathology, 1992
- Antibiotic sensitivities ofNeisseria meningitidisisolates from patients and carriers in GreeceEpidemiology and Infection, 1992
- Penicillin sensitivity of gonococci in Australia: development of Australian gonococcal surveillance programme. Members of the Australian Gonococcal Surveillance Programme.Sexually Transmitted Infections, 1984